Novaseek’s award-winning CDNR platform provides access to real world data and supports the ability to define and track patient cohorts based on detailed clinical criteria such as demographics, diagnoses, medications, and lab test results, and supports the collection of biospecimens at various time points for translational medicine, clinical development and post-launch observational studies.
The CDNR platform offers a turn-key intuitive user experience and data interactivity. Typically, patient clinical phenotype data is very limited compared to extremely detailed biological data that can be generated from the biospecimen. CNDR enables researchers to obtain detailed clinical information with every biospecimen, to ensure clinical relevance and significance of every experiment and every study.
Novaseek supports collections of biospecimens and data for oncology, inflammatory, cardiovascular, metabolic/diabetes, auto-immune, endocrine, neurology, and multiple other studies.
The CDNR provides access to biospecimens and data from Novaseek’s network of healthcare organizations. With quick and easy implementation, the CDNR can also be licensed for use at study sponsor’ existing clinical sites.
You can rely on the CDNR platform to generate new insights, increase R&D productivity and decrease project risk in the pursuit of new medical advances.
Find Out More